The patented Safe-2-Dose™ Integrated Dosing Container is the next generation Infants elixir dispenser providing enhanced medication dosing accuracy and user convenience. The caregiver need only disabl
At Asepsis, our goal is to seek global collaboration for the integration of our proprietary delivery enhancements to existing or prospective marketed medicinal solutions, for line extensions and therapeutic differentiation.
Our portfolio focuses on enhancing medication efficacy and safety by providing higher precision adherence to established optimal clinical dosing, while in parallel reducing user preparation and administration sequences.
We are always looking to expand our existing product portfolios in existing or unoccupied markets through:
♦ IP acquisition
♦ Licensing arrangements
♦ Development collaborations
♦ Exclusive territory representation
♦ Patent and/or product exclusivity
Asepsis Medical Technologies LLC
1584 Independence Blvd.
Sarasota, FL 34234
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra